Abstract
Cholera is a bacterial water-borne diarrheal disease transmitted via the fecal-oral route that causes high morbidity in sub-Saharan Africa and Asia. It is preventable with vaccination, and Water, Sanitation, and Hygiene (WASH) improvements. However, the impact of vaccination in endemic settings remains unclear. Cholera is endemic in the city of Kalemie, on the shore of Lake Tanganyika, in the Democratic Republic of Congo, where both seasonal mobility and the lake, a potential environmental reservoir, may promote transmission. Kalemie received a vaccination campaign and WASH improvements in 2013-2016. We assessed the impact of this intervention to inform future control strategies in endemic settings.
We fit compartmental models considering seasonal mobility and environmentally-based transmission. We estimated the number of cases the intervention avoided, and the relative contributions of the elements promoting local cholera transmission.
We estimated the intervention avoided 5,259 cases (95% credible interval: 1,576.6-11,337.8) over 118 weeks. Transmission did not rely on seasonal mobility and was primarily environmentally-driven. Removing environmental exposure or contamination could control local transmission.
Repeated environmental exposure could maintain high population immunity and decrease the impact of vaccination in similar endemic areas. Addressing environmental exposure and contamination should be the primary target of interventions in such settings.
Author summary Cholera is a major global health concern that causes high morbidity. It is a bacterial water-borne disease that can be transmitted via the fecal-oral route or the ingestion of contaminated water. Hence, both population mobility and environmental exposure can promote cholera persistence. The primary tools to prevent cholera include vaccination and Water, Sanitation, and Hygiene (WASH) improvements. The effectiveness of these interventions is well understood in epidemic settings, but their impact in endemic settings is unclear. Achieving cholera elimination requires disentangling the contributors to transmission, specifically population mobility and aquatic reservoirs, and assessing the impact of interventions performed in endemic settings.
This study focuses on Kalemie, a cholera endemic city in the Democratic Republic of Congo, on shore of a lake that serves as a potential environmental reservoir. It quantifies the short-term impact of an intervention that used targeted vaccination and WASH. The study shows that the impact of vaccination was dampened by very high background immunity due to constant environmental exposure. This suggests that WASH improvements should be the primary intervention in such settings despite the time- and resource-intensive nature of implementation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported by the joint National Institutes of Health (NIH) - National Science Foundation (NSF) - National Institute of Food and Agriculture (NIFA) Ecology and Evolution of Infectious Disease (award R01TW012434 to NB), NSF DEB RAPID (award 2202872 to NB), and NSF DMS (award 2015273 to EH). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Ethical Review Board of the University of Lubumbashi gave ethical approval the study protocol to assess the impact of the vaccination campaign (study protocol ethical number: UNILU/CEM/028/2013) and its extension (study protocol ethical number: UNILU/CEM/050/2015). Individuals provided informed consent to be part of the vaccine coverage survey. Pennsylvania State University Institutional Review Board determined the post-intervention handling and analyses of these anonymized data was Not Human Research (STUDY00015621).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
We explored the robustness of our assumption regarding constant reporting rate when using reported suspected cholera cases. We updated our model selection strategy relying on WAIC rather than DIC and also compared our model structure to alternative simple structures: one model without bacterial growth and one model without environmental reservoir. We also expanded our convergence checks by adding one chain and calculating Gelman and Rubin statistics. Finally, we added a sensitivity analysis by fitting a model assuming a leaky vaccine.
Data Availability
The weekly aggregated number of suspected cholera cases can be requested by contacting Klaudia Porten (Klaudia.PORTEN{at}epicentre.msf.org). All additional data and code necessary to reproduce the analysis and the figures are available online at https://github.com/bhartilab/cholera_kalemie
